Assignee
ACTIVE BIOTECH AB
SE·37 granted patents·14 pending applications·893 citations·filing 1995–2025
Top patents by PatentIndex Score
51 records- 0195US7615225B2Methods for treating a subject having cancer by the administration of a conjugate between a variant staphylococcal entertoxin E superantigen and an antibody that binds to the 5T4 antigenACTIVE BIOTECH AB·Filed 2006·Granted Nov 10, 2009·52 cites·51 claims
- 0295US6875869B2Process for the manufacture of quinoline derivativesACTIVE BIOTECH AB·Filed 2003·Granted Apr 5, 2005·79 cites·6 claims
- 0394US7763253B2Treatment of hyperproliferative disease with superantigens in combination with another anticancer agentACTIVE BIOTECH AB·Filed 2005·Granted Jul 27, 2010·63 cites·57 claims
- 0494US7125554B2Engineered superantigen for human therapyACTIVE BIOTECH AB·Filed 2001·Granted Oct 24, 2006·71 cites·49 claims
- 0594US6593343B2Quinoline derivativesACTIVE BIOTECH AB·Filed 2002·Granted Jul 15, 2003·60 cites·15 claims
- 0694US6077851AQuinoline derivativesACTIVE BIOTECH AB·Filed 1999·Granted Jun 20, 2000·139 cites·40 claims
- 0793US7589208B2Compositions containing quinoline compoundsACTIVE BIOTECH AB·Filed 2005·Granted Sep 15, 2009·51 cites·32 claims
- 0893US7226595B2Modified Chimeric superantigens and their useACTIVE BIOTECH AB·Filed 2002·Granted Jun 5, 2007·69 cites·9 claims
- 0993US6395750B1Drugs for the treatment of malignant tumorsACTIVE BIOTECH AB·Filed 2000·Granted May 28, 2002·79 cites·66 claims
- 1092US6605616B1Quinoline derivativesACTIVE BIOTECH AB·Filed 2000·Granted Aug 12, 2003·40 cites·18 claims
- 1188US11478465B2Compounds for treatment of eye diseases associated with excessive vascularisationACTIVE BIOTECH AB·Filed 2021·Granted Oct 25, 2022·4 cites·15 claims
- 1287US6133285AQuinoline derivativesACTIVE BIOTECH AB·Filed 1999·Granted Oct 17, 2000·62 cites·41 claims
- 1385US6121287AQuinoline derivativesACTIVE BIOTECH AB·Filed 1999·Granted Sep 19, 2000·68 cites·38 claims
- 1485US2025134881A1Treatment of ocular inflammatory diseases using laquinimodACTIVE BIOTECH AB·Filed 2024·Application pending·0 cites
- 1583US7074831B2Compounds, methods for their preparation and use thereofACTIVE BIOTECH AB·Filed 2005·Granted Jul 11, 2006·10 cites·17 claims
- 1678US9956212B2Quinoline carboxamides for use in the treatment of multiple myelomaACTIVE BIOTECH AB·Filed 2015·Granted May 1, 2018·4 cites·20 claims
- 1774US7553849B2CompoundsACTIVE BIOTECH AB·Filed 2005·Granted Jun 30, 2009·2 cites·21 claims
- 1873US6642249B2Immunomodulating compoundsACTIVE BIOTECH AB·Filed 2002·Granted Nov 4, 2003·8 cites·22 claims
- 1973US2021386731A1Treatment of ocular inflammatory diseases using laquinimodACTIVE BIOTECH AB·Filed 2021·Application pending·0 cites
- 2073US2026076908A1Plurality of tasquinimod particles and use thereofACTIVE BIOTECH AB·Filed 2025·Application pending·0 cites
- 2171US12485095B2Plurality of tasquinimod particles and use thereofACTIVE BIOTECH AB·Filed 2022·Granted Dec 2, 2025·0 cites·17 claims
- 2271US6518312B2Immune enhancementACTIVE BIOTECH AB·Filed 2001·Granted Feb 11, 2003·4 cites·14 claims
- 2370US7291612B2Immunomodulatory compoundsACTIVE BIOTECH AB·Filed 2006·Granted Nov 6, 2007·2 cites·19 claims
- 2467US12208091B2Compounds for treatment of eye diseases associated with excessive vascularisationACTIVE BIOTECH AB·Filed 2022·Granted Jan 28, 2025·0 cites·15 claims
- 2567US10300053B2Quinoline carboxamides for use in the treatment of leukemiaACTIVE BIOTECH AB·Filed 2015·Granted May 28, 2019·1 cites·18 claims
- 2666US7226601B1Conjugate between a modified superantigen and a target-seeking compound and the use of the conjugateACTIVE BIOTECH AB·Filed 1995·Granted Jun 5, 2007·13 cites·2 claims
- 2765US7425623B2Antibody with specificity for colon cancerACTIVE BIOTECH AB·Filed 2001·Granted Sep 16, 2008·2 cites·13 claims
- 2864US2010111978A1Conjugates between a variant staphylococcal enterotoxin e superantigen and a targeting antibody that binds to a cancer-associated cell surface structureACTIVE BIOTECH AB·Filed 2009·Application pending·0 cites
- 2963US11654140B2Treatment of ocular inflammatory diseases using laquinimodACTIVE BIOTECH AB·Filed 2017·Granted May 23, 2023·0 cites·25 claims
- 3062US10314836B2Quinoline carboxamides for use in the treatment of multiple myelomaACTIVE BIOTECH AB·Filed 2018·Granted Jun 11, 2019·0 cites·12 claims
- 3162US7081456B2Immunomodulatory compoundsACTIVE BIOTECH AB·Filed 2003·Granted Jul 25, 2006·2 cites·20 claims
- 3261US8754104B2Crystalline salts of quinoline compounds and methods for preparing themACTIVE BIOTECH AB·Filed 2012·Granted Jun 17, 2014·0 cites·20 claims
- 3361US7189816B1CompoundsACTIVE BIOTECH AB·Filed 2000·Granted Mar 13, 2007·4 cites·10 claims
- 3461US2005226885A1Cytolysis of target cells by superantigen conjugates inducing T-cell activationACTIVE BIOTECH AB·Filed 2004·Application pending·0 cites
- 3560US10385069B2Imidazo[2,1-B]thiazole and 5,6-dihydroimidazo[2,1-B]thiazole derivatives useful as S100-inhibitorsACTIVE BIOTECH AB·Filed 2015·Granted Aug 20, 2019·1 cites·18 claims
- 3660US2024091215A1Tasquinimod or a pharmaceutically acceptable salt thereof for use in the treatment of myelodysplastic syndromeACTIVE BIOTECH AB·Filed 2022·Application pending·0 cites
- 3759US2024122915A1Combination of tasquinimod or a pharmaceutically acceptable salt thereof and a pd-1 and/or pd-l1 inhibitor, for use as a medicamentACTIVE BIOTECH AB·Filed 2023·Application pending·0 cites
- 3855US2024277693A1A pharmaceutical product containing tasquinimod and a method for assessing the purity of said productACTIVE BIOTECH AB·Filed 2022·Application pending·0 cites
- 3954US2007112179A1Novel compoundsACTIVE BIOTECH AB·Filed 2006·Application pending·0 cites
- 4052US12582643B2Tasquinimod or a pharmaceutically acceptable salt thereof for use in combination therapyACTIVE BIOTECH AB·Filed 2021·Granted Mar 24, 2026·0 cites·13 claims
- 4152US2024180819A1Laquinimod formulation for ocular useACTIVE BIOTECH AB·Filed 2022·Application pending·0 cites
- 4250US9873687B2N-(heteroaryl)-sulfonamide derivatives useful as S100-inhibitorsACTIVE BIOTECH AB·Filed 2014·Granted Jan 23, 2018·0 cites·21 claims
- 4350US2004146531A1Virus-like particles devoid of HPV 16 type-specific antibody epitopes as carriers of peptides for introduction into cellsACTIVE BIOTECH AB·Filed 2004·Application pending·0 cites
- 4449US2020129499A1Combination of tasquinimod or a pharmaceutically acceptable salt thereof and a pd-1 and/or pd-l1 inhibitor, for use as a medicamentACTIVE BIOTECH AB·Filed 2019·Application pending·0 cites
- 4546US10125125B2N-(heteroaryl)-sulfonamide derivatives useful as S100-inhibitorsACTIVE BIOTECH AB·Filed 2017·Granted Nov 13, 2018·0 cites·39 claims
- 4641US7339059B2Benzofurans and indolsACTIVE BIOTECH AB·Filed 2004·Granted Mar 4, 2008·0 cites·3 claims
- 4740US7674906B2Tetracyclic immunomodulatory compoundsACTIVE BIOTECH AB·Filed 2003·Granted Mar 9, 2010·0 cites·16 claims
- 4840US2008119485A1Novel Benzofurans and IndolsACTIVE BIOTECH AB·Filed 2008·Application pending·0 cites
- 4935US6727062B1Identification of target structures E.G. in vivo selection method for a phage libraryACTIVE BIOTECH AB·Filed 1999·Granted Apr 27, 2004·3 cites·34 claims
- 5031US2005192289A1Novel cinnamic amidesACTIVE BIOTECH AB·Filed 2004·Application pending·0 cites
Showing the top 50 of 51 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when ACTIVE BIOTECH AB files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →